Progenics Pharmaceuticals Overview

Life ScienceCompany

Where is Progenics Pharmaceuticals headquartered?

Progenics Pharmaceuticals is headquartered in Tarrytown, New York.

What is Progenics Pharmaceuticals’ revenue?

Progenics Pharmaceuticals disclosed revenue of 16M USD for 2018 and 12M USD for 2017.

How many employees does Progenics Pharmaceuticals have?

Progenics Pharmaceuticals has 79 employees.

What sector is Progenics Pharmaceuticals in?

Progenics Pharmaceuticals is a life science company.

When was Progenics Pharmaceuticals founded?

Progenics Pharmaceuticals was founded in 1986.

Progenics Pharmaceuticals, Inc.

One World Trade Center 47th Floor Suite J,
Tarrytown, New York 10007
United States,
(646) 975-2500
www.progenics.com

Progenics Pharmaceuticals, Inc. is a pharmaceutical company provides medicines to treat disease, focusing on cancer and related conditions with a pipeline that includes product candidates in preclinical through late-stage development. Progenics Pharmaceuticals was founded in 1986 and is based in New York City, New York.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
vol $106M $106M
Sell (0.0/yr) # - - - - - - 0
  1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.